Article
Analyzing human knockouts to validate GPR151 as a therapeutic target for reduction of body mass index
2021-10-26
Abstract excerpt
Novel drug targets for sustained reduction in body mass index (BMI) are needed to curb the epidemic of obesity, which affects 650 million individuals worldwide and is a causal driver of cardiovascular and metabolic disease and mortality. Previous studies reported that the Arg95Ter nonsense variant of GPR151, an orphan G protein-coupled receptor, is associated with reduced BMI and reduced risk of Type 2 Diabetes (T...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b82646ac-186d-5c10-9c9b-82c89ebcbd6b
- DOI
- 10.1101/2021.10.21.21264378
